Alcohol and drugs as co-factors for AIDS. NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Alcohol and drugs as co-factors for AIDS.

Adv Alcohol Subst Abuse. 1987;7(2):47-71. Unique Identifier : AIDSLINE MED/88206997
MacGregor RR; Department of Medicine, University of Pennsylvania School of; Medicine, Philadelphia 19104.

Abstract: Opiate use in humans is associated with a reduction in the number of circulating T-lymphocytes and in their ability to undergo transformation, probably resulting from opiate binding to T-cell antigens. (See Table 4). Patients also manifest a diffuse hyperglobulinemia, without change in circulating B-cell numbers. In vitro exposure of rodent and human lymphocytes to cannabinoids depresses their transformation, natural killer activity, and interferon production. Similar results occur with in vivo exposure of rodents, but data in man are mixed. Cannabinoids also inhibit primary and secondary antibody responses in rodents. Data regarding the effects of CNS stimulants are too scanty to allow comment. Barbiturate anesthesia in man and animals produces a short-lived depression of lymphocyte transformation, NK activity, and ADCC; no studies of the effects of chronic exposure have been performed. Amyl nitrite has not been proven to possess any immunosuppressive activity.
Keywords: Acquired Immunodeficiency Syndrome/*IMMUNOLOGY Alcoholism/*COMPLICATIONS Human Immune Tolerance Immunocompetence Risk Factors Substance Abuse/*COMPLICATIONS Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL

KWDacquiredimmunodeficiencysyndrome/KWDimmunologyalcoholism/KWDcomplicationshumanimmunetoleranceimmunocompetenceriskfactorssubstanceabuse/KWDcomplicationssupport,uKWDsKWDgov't,pKWDhKWDsKWDjournalarticlereviewreview,tutorial
880830
M8880482

Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .